Topics
Note: (K) = Keynote Speaker (45 minutes);
(P) = Plenary Speaker (35 minutes);
(N) = Named Speaker (35 minutes);
(A)= Award presentation (30 minutes) S=session


Time

Topics

Room

Thursday, 29 June (DAY 1)

19:00-20:30

Yigong Shi (K), Tsinghua University
Hans Clevers (K), Hubrecht Institute

 

Friday, 30 June (DAY 2)

8:00-8:45

Zhu Chen (K), Shanghai Jiao Tong University

 

8:45-9:20

Xiaofeng Cao (P), Institute of Genetics and Developmental Biology, CAS

 

9:40-10:55

S1. An Emergin Area of Targeted Cancer Therapy: DNA Damagae Repair and Signaling Pathways

 

S2. Cancer metabolism and beyond

 

S3. Innate Immune Responses and Inflammation

 

S4. Precision Medicine-Gene Based Therapy

 

S5. Mechanisms and therapy of neurodegenerative diseases 

 

11:15-12:30

S6. New Frontier of Cancer Metastasis Research: From Lab Bench to Bedside

 

S7. Hematological malignancies

 

S8. Biomotors, single-pore sensing and RNA nanotechnology

 

S9. Cell death and inflammasome signaling in normal physiology and diseases

 

S10. Nuclear Receptor Function and Diseases

 

14:00- 14:35

Jake Liang (N),

 

14:35- 15:05

Keji Zhao (A),

 

15:25-16:40

S11. Metabolic risk factors and liver cancer

 

S12. Systemic Mechanisms of Aging

 

S13. New Concepts of Radiation Biology: its implication in human health and cancer therapy

 

S14. Human iPSC-based modeling of neurodevelopment and diseases

 

S15. Drug Discovery & Biomarkers

 

Saturday, 1 July (DAY 3)

8:00-8:45

Melanie Cobb (K)

 

8:45-9:20

Yifan Cheng (P)

 

9:40-10:55

S16. Mucosal Immunity and Associated Diseases

 

S17. Wnt signaling in development, stem cells, and cancer

 

S18. Novel Molecular Landscapes Leading to Prostate Cancer Progression

 

S19. Mechanisms of Genomic Instability Syndromes: From Genetics To Genomics

 

S20. Neurodevelopment and disorders

 

11:15-12:30

S21. Genomic and Nongemoic Signaling and Functions of Steroids and Their Receptors

 

S22. Retinal Function and Diseases

 

S23. Energy and Glucose Homeostasis: A Symphony by the Neuro-Immuno-Endocrine Orchestra

 

S24. Cure of Chronic Viral Hepatitis

 

S25. Liver Cancer : Prognostic Biomarkers, Surveillance and Prevention

 

14:00- 15:05

S26. Cullin-RING ligase and protein neddylation in cancer biology

 

S27. Regulatory T cells in cancers and autoimmune diseases

 

S28. Genomic and functional studies of human leukemia

 

S29. Stem cells: engineering and disease modeling

 

S30. Metabolic Targets for Cancer Therapy

 

15:25-16:40

S31. Epigenetics and Hamatological Malignancies

 

S32. Recent Advances in Cancer Research

 

S33. Immunotherapy

 

S34. Synaptic plasticity

 

S35. Frontiers of Liver Cancer Research

 

Sunday, 2 July (DAY 4)

8:00-8:45

Irving Weissman (K)

 

8:45-9:20

Liqun Lou (P)

 

9:40-10:55

S36. Paradoxical TGF‐beta Signaling in Development, Diseases and Therapeutics

 

 

S37. Therapeutic Resistance in Prostate Cancer

 

 

S38. Mechanisms of embryogenesis and organogenesis

 

 

S39. p53, Metabolism, and Cancer

 

 

S40. Genome maintenance, DNA Repair and Recombination

 

11:15-12:30

S41. Communication between transcription and histone regulation

 

S42. Fibrosis-molecular mechanisms and future therapeutics

 

S43. Neural development and related diseases

 

S44. Ubiquitin signaling in inflammation and cancer

 

S45. Neural circuit of behavior

 

14:00- 14:35

Dihua Yu (N)

 

14:35- 15:05

Feng Shao (A)

 

15:25-16:40

S46. Transcription Mechanisms and Human Diseases

 

S47. Blood cell research and treatment: leading precision & regenerative medicine again in the next decade

 

S48. Recombinant fusion proteins as novel therapeutics

 

S49. New Insights on Alcoholic and Nonalcoholic Liver Diseases: Organ Crosstalk and Mechanisms

 

S50. Function and mechanism of Hedgehog signaling in development and diseases

 

Monday, 3 July (DAY 5)

8:30-9:15

Jiayang Li (K)

 

9:15-9:50

Chuan He (P)

 

10:30-11:00

Lieping Chen (A)

 

11:00-11:30

Mien-Chie Hung (A)